Dentsply Sirona Implants and Consumables
Trial Pipeline
A Prospective Multicenter Clinical Investigation Evaluating the Accuracy of the Trimline Design When Treated With SureSmile® Aligners.
NCT07290790
Clinical Study of a 3D Shaded Zirconia for Chairside CAD/CAM Restorations
NCT06713577
Clinical Evaluation of Implants Restored With Advanced Lithium Disilicate Screw-retained Crowns
NCT05752539
Multicenter Study to Evaluate the Clinical Outcome of PrimeTaper EV Implant in Single Tooth Restorations
NCT05315414
A Clinical Study on Acuris™ - Conometric Concept for Single Tooth Restoration
NCT04063878
Study Comparing Appearance and Function of Three Different Dental Implant Designs When Placed in Front Region of Upper Jaw
NCT00820235
Study to Evaluate an Implant With a Sloped Top in Patients With a Sloped Jaw Bone
NCT00807456
Study on OsseoSpeed™ Implants Replacing 2-5 Teeth in the Posterior Upper Jaw, Restored With Provisional Teeth Attached 6-7 Weeks Later
NCT00711113
Therapeutic Areas
What the Pipeline for Dentsply Sirona Implants and Consumables Shows
According to the ClinicalTrials.gov registry, Dentsply Sirona Implants and Consumables is linked to 8 US clinical trials across every stage of research activity. Of those, 1 studies are currently recruiting — about 13% of the sponsor's indexed portfolio — and 3 are already marked complete, representing roughly 38% of the total. Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
The phase mix for Dentsply Sirona Implants and Consumables reports 0 late-stage studies (Phase 3 and Phase 4 combined) and 0 earlier-phase studies (Phase 1 and Phase 2). A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work — safety, dosing, and early signal detection — and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
The top therapeutic focus area indexed for Dentsply Sirona Implants and Consumables is Jaw, Edentulous, Partially with 4 linked trials, and 4 other condition areas appear in the top list above. That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice — verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology — how this data is sourced, computed, and verified.